Promising vaccine candidates are on the horizon, with expectations of identifying effective options by early next year. Despite the potential for herd immunity with just 60% vaccination, the U.S. lags behind other developed nations due to a weakened public health infrastructure and a hesitant population. The complexities of public perception and leadership caution highlight the challenges in navigating this unprecedented health crisis.
